1204512-57-1 Usage
Description
Cyclopropyl-[(1S,4S)-4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphthalen-1-yl]-Methyl-aMine is a chiral amine compound characterized by the presence of a cyclopropyl group, a tetrahydro-naphthalen-1-yl group, and a 3,4-dichloro-phenyl group. It features a stereocenter at the 1 and 4 positions of the tetrahydro-naphthalene ring, which may contribute to its potential biological activities and applications in pharmaceutical research and drug development.
Uses
Used in Pharmaceutical Research and Drug Development:
Cyclopropyl-[(1S,4S)-4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphthalen-1-yl]-Methyl-aMine is used as a building block for the synthesis of pharmaceuticals due to its unique structural features and potential biological activities. Its chiral nature and diverse functional groups may allow for the development of novel drugs with specific therapeutic effects.
Used in Coordination Chemistry:
Cyclopropyl-[(1S,4S)-4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphthalen-1-yl]-Methyl-aMine may also be utilized as a ligand in coordination chemistry, where it can form complexes with metal ions. These metal complexes may exhibit interesting properties and applications, such as in catalysis or as potential therapeutic agents.
Further research and studies are necessary to fully explore the potential uses and properties of Cyclopropyl-[(1S,4S)-4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphthalen-1-yl]-Methyl-aMine, as well as to optimize its synthesis and application in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1204512-57-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,4,5,1 and 2 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1204512-57:
(9*1)+(8*2)+(7*0)+(6*4)+(5*5)+(4*1)+(3*2)+(2*5)+(1*7)=101
101 % 10 = 1
So 1204512-57-1 is a valid CAS Registry Number.
1204512-57-1Relevant articles and documents
New sertraline analogue, preparation method and applications thereof
-
Paragraph 0096; 0100-0102; 0104, (2020/01/12)
The invention belongs to the technical field of compounds, preparation methods and applications thereof, and specially relates to a sertraline analogue or a pharmaceutically acceptable salt thereof, wherein the sertraline analogue has a structure represented by the following formula (I), and the compound has good pharmaceutical activity compared with sertraline. The invention further provides a preparation method and applications of the compound represented by the formula (I).
